Come up with a name for your new list and we'll add to it:
BioMarck Pharmaceuticals raised a round of funding on September 17, 2009. Investors include
National Institutes of Health.
BioMarck Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of …